News
Vicky Pattison just shared with fans she's been loving this LED hair growth helmet from CurrentBody that promises to reduce ...
Systemic Lupus Erythematosus (about 70% of cases are systemic); Discoid Lupus Cutaneous, which is limited to the skin; and Drug Induced Lupus, which occurs most commonly with drugs used to treat ...
Now I've Seen Everything on MSN4d
8 Celebrities Who Proudly Embrace Their Unique FeaturesUnique and unusual physical features have long intrigued us, often making individuals stand out in unforgettable and ...
The management of inflammatory arthritis may just require NSAIDs or low-dose corticosteroids whereas cutaneous disease, such as discoid lupus, may be treated with topical corticosteroids or with ...
Bowl of Quick Cook on MSN6d
Living with the 'Cruel Mystery': Navigating the Unpredictable Journey of Lupus, Shared by Stars and ExpertsThis unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease ...
People with lupus can have cognitive symptoms, like having a hard time thinking clearly or remembering things. This is also called “brain fog” or “lupus fog,” and it often comes and goes over time. In ...
Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...
The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. A charitable organization with ...
UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.
Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus ...
The Lupus Foundation of America says the disease affects an estimated 1.5 million Americans, 90% of them being women. Major lupus research projects are taking place in Utica. The institute is ...
Objective One key target of treating patients with systemic lupus erythematosus (SLE) is to prevent organ damage. This analysis quantified the association between time spent in four specific SLE low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results